586-10-7Relevant articles and documents
Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1
Goodnow, Robert A.,Hicks, Alexandra,Sidduri, Achyutharao,Kowalczyk, Agnieszka,Dominique, Romyr,Qiao, Qi,Lou, Jian Ping,Gillespie, Paul,Fotouhi, Nader,Tilley, Jefferson,Cohen, Noal,Choudhry, Satish,Cavallo, Gary,Tannu, Shahid A.,Ventre, Jessica D.,Lavelle, Danielle,Tare, Nadine S.,Oh, Hyesun,Lamb, Martin,Kurylko, Grazyna,Hamid, Rachid,Wright, Matthew B.,Pamidimukkala, Anjula,Egan, Thomas,Gubler, Ueli,Hoffman, Ann F.,Wei, Xin,Li, Ying L.,O'Neil, John,Marcano, Ruben,Pozzani, Karen,Molinaro, Tina,Santiago, Jennifer,Singer, Laura,Hargaden, Maureen,Moore, David,Catala, A. Robert,Chao, Lisa C. F.,Hermann, Gesine,Venkat, Radhika,Mancebo, Helena,Renzetti, Louis M.
experimental part, p. 3502 - 3516 (2010/09/08)
The inhibition of LTB4 binding to and activation of G-protein-coupled receptors BLT1 and BLT2 is the premise of a treatment for several inflammatory diseases. In a lead optimization effort starting with the leukotriene B4 (LTB4
Coupling compounds and hair dyeing compositions containg them
-
Page/Page column 9, (2008/06/13)
The present invention refers to Compound of the formula (I) wherein X is oxygen or sulphur; R1 is (C1-C4)-alkyl, (C1-C4)-alkyl which is substituted by hydroxy, (C1-C4)-alkoxy, hy
Substituted benzamide inhibitors of rhinovirus 3C protease
-
Page column 12-13, (2010/01/31)
Nonpeptide benzamide-containing inhibitors of human rhinovirus (HRV) 3C protease are described.